The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
May 30, 2025, 3:30 PM EDT - 25 days ago
AGNG ARKG BBC BBH BBP BIB BMED
May 14, 2025, 3:23 PM EDT - 5 weeks ago
BITU BITX ETHT ETHU EVAV GDXU JNUG
Feb 25, 2025, 11:06 AM EST - 4 months ago
IBB XLV AGNG ARKG BBC BBH BBP
Aug 8, 2022, 6:12 PM EDT - 3 years ago
DOG DUG DXD MYY MZZ PSQ QID